Sprint Bioscience AB (publ) (STO:SPRINT)
3.680
-0.120 (-3.16%)
Nov 20, 2026, 5:29 PM CET
Sprint Bioscience AB Market Cap
Sprint Bioscience AB has a market cap or net worth of 388.3 million as of November 20, 2026. It is the 31,536th most valuable company in the world and the 425th biggest in Sweden. Its market cap has increased by 433.33% in one year.
Market Cap
388.30M
Enterprise Value
310.78M
Revenue
134.13M
Global Rank
Country Rank
#425 Sweden
PE Ratio
5.66
ChartMarket Cap Chart
Since November 7, 2014, Sprint Bioscience AB's market cap has increased from 62.49M to 388.30M, an increase of 521.33%. That is a compound annual growth rate of 16.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 388.30M | 150.34% |
| Dec 30, 2025 | 155.11M | 40.43% |
| Dec 30, 2024 | 110.46M | -8.82% |
| Dec 29, 2023 | 121.14M | 449.78% |
| Dec 30, 2022 | 22.03M | -88.47% |
| Dec 30, 2021 | 191.05M | 17.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SynAct Pharma AB | 727.98M |
| Medivir AB | 651.64M |
| Oncopeptides AB | 648.27M |
| Xspray Pharma AB | 482.70M |
| FluoGuide | 482.30M |
| Corline Biomedical AB | 365.86M |
| Cantargia AB | 363.43M |
| Isofol Medical AB | 317.29M |